{"id":2683,"date":"2026-05-04T04:50:50","date_gmt":"2026-05-04T04:50:50","guid":{"rendered":"https:\/\/pm11.corsivalab.xyz\/sciencewerke\/reduction-of-activin-a-gives-rise-to-comparable-expression-of-key-definitive-2\/"},"modified":"2026-05-04T04:50:51","modified_gmt":"2026-05-04T04:50:51","slug":"reduction-of-activin-a-gives-rise-to-comparable-expression-of-key-definitive-2","status":"publish","type":"post","link":"https:\/\/pm11.corsivalab.xyz\/sciencewerke\/reduction-of-activin-a-gives-rise-to-comparable-expression-of-key-definitive-2\/","title":{"rendered":"Reduction of Activin A gives rise to comparable expression of\n                                key definitive\n                                endoderm and mature beta cell markers"},"content":{"rendered":"<figure class=\"project-feature\">\n<img decoding=\"async\" alt=\"sciencewerke\" class=\"img\" src=\"http:\/\/sciencewerke.local\/wp-content\/uploads\/2026\/04\/img21-1-1.jpg\"\/><br \/>\n<\/figure>\n<p><\/p>\n<p class=\"text-justify\">\n<strong>CET human iPS cells<\/strong> were cited in a recent issue of Regenerative Medicine<br \/>\n                        evaluating <strong>methods to differentiate human stem cells into insulin-producing<br \/>\n                            cells.<\/strong>\n<\/p>\n<p class=\"text-justify\">\n                        CET provides researchers with<strong> high-performing and scalable iPS cell lines<\/strong> and<br \/>\n                        <strong> lowering the cost of therapeutic development<\/strong> with their high-performing,<br \/>\n                        low-cost<br \/>\n                        growth factors.\n                    <\/p>\n<p class=\"text-justify mb-3 mt-3\">\n<a href=\"https:\/\/www.sciencewerke.com\/images\/CET_Citation_in_Regenerative_Medicine_Journal.pdf\" onmouseout=\"this.style.textDecoration='none'\" onmouseover=\"this.style.textDecoration='underline'\" rel=\"noopener noreferrer\" style=\"text-decoration: none; color :#178fcf\" target=\"_blank\"><br \/>\n                            Click here to read the full article.<br \/>\n                        <\/a>\n<\/p>\n<p class=\"text-justify mb-2\">\n                    Reach out to any of our Sciencewerke sales representatives at<br \/>\n                        <a href=\"mailto:enquiry@sciencewerke.com\" onmouseout=\"this.style.textDecoration='none'\" onmouseover=\"this.style.textDecoration='underline'\" style=\"text-decoration: none; color :#178fcf\">enquiry@sciencewerke.com<\/a> or call us at:<br \/>\n                        <a href=\"tel:+6567771045\" onmouseout=\"this.style.textDecoration='none'\" onmouseover=\"this.style.textDecoration='underline'\" style=\"text-decoration: none; color :#178fcf\">6777 1045<\/a> to learn how the CD34+ and<br \/>\n                            Multipotent iPSCs can accelerate your research and development efforts.\n                    <\/p>\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>CET human iPS cells were cited in a recent issue of Regenerative Medicine evaluating methods to differentiate human stem cells into insulin-producing cells. CET provides researchers with high-performing and scalable iPS cell lines and lowering the cost of therapeutic development with their high-performing, low-cost growth factors. Click here to read the full article. Reach out [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":287,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[164],"tags":[],"class_list":["post-2683","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-164"],"_links":{"self":[{"href":"https:\/\/pm11.corsivalab.xyz\/sciencewerke\/wp-json\/wp\/v2\/posts\/2683","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pm11.corsivalab.xyz\/sciencewerke\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pm11.corsivalab.xyz\/sciencewerke\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pm11.corsivalab.xyz\/sciencewerke\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/pm11.corsivalab.xyz\/sciencewerke\/wp-json\/wp\/v2\/comments?post=2683"}],"version-history":[{"count":1,"href":"https:\/\/pm11.corsivalab.xyz\/sciencewerke\/wp-json\/wp\/v2\/posts\/2683\/revisions"}],"predecessor-version":[{"id":2748,"href":"https:\/\/pm11.corsivalab.xyz\/sciencewerke\/wp-json\/wp\/v2\/posts\/2683\/revisions\/2748"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pm11.corsivalab.xyz\/sciencewerke\/wp-json\/wp\/v2\/media\/287"}],"wp:attachment":[{"href":"https:\/\/pm11.corsivalab.xyz\/sciencewerke\/wp-json\/wp\/v2\/media?parent=2683"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pm11.corsivalab.xyz\/sciencewerke\/wp-json\/wp\/v2\/categories?post=2683"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pm11.corsivalab.xyz\/sciencewerke\/wp-json\/wp\/v2\/tags?post=2683"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}